MIRA
INFORM REPORT
|
Report Date : |
09.02.2012 |
IDENTIFICATION DETAILS
|
Name : |
LEK D.D. |
|
|
|
|
Formerly Known As : |
NOVARTIS PHARMA D.O.O. |
|
|
|
|
Registered Office : |
Verovskova ulica 57 1000
Ljubljana |
|
|
|
|
Country : |
Slovenia |
|
|
|
|
Financials (as on) : |
31.12.2010 |
|
|
|
|
Date of Incorporation : |
14.08.2002 |
|
|
|
|
Com. Reg. No.: |
13654200 |
|
|
|
|
Legal Form : |
Joined Stocked Company |
|
|
|
|
Line of Business : |
Manufacture of pharmaceutical preparations |
|
|
|
|
No. of Employees : |
2472 |
RATING & COMMENTS
|
MIRAs Rating : |
A |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
Maximum Credit Limit : |
10.000.000 EUR |
|
Status : |
Good |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List September 30, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
Slovenia |
B1 |
B1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Company name and address
|
Lek d.d. |
Phone |
01 580 21 11 |
|
Verovskova ulica 57 |
Telefax |
01 568 35 17 |
|
1000 Ljubljana |
E-Mail |
|
|
Slovenia |
Web |
Crefo Nr. 9270022631
Statistical Nr. 1732811
Tax Nr. SI87916452
Registration: Ljubljana
Registration Nr. 13654200
Status
Economic situation
Business connection Business connection are premissible (21)
Terms of payment Within agreed terms (21)
Credit Limit 10.000.000 EUR
Basic information
Legal form
Joined stocked Company
Founded
14/08/2002 as d.o.o. -
Limited liability company (Ltd.) 21/07/2004 as Joined stocked Company
last entry
on 09.09.2011
original
with the company name Novartis Pharma d.o.o. since 10.07.2003 with the company
name Novartis Pharma Storitve d.d.,
since
30.9.2004 with the company name Lek d.d.
on
30.9.2004 incorporation of the
daughter
company LEK d.d. (company nu. 5043425,
established
already in 1946) into
parent
company Novartis Pharma Storitve d.d. and
at the
same time change of the company name from Novartis
Pharma
Storitve d.d. into Lek d.d.
the
company LEK d.d. (company nu. 5043425) was
on
7.12.2004 from the register erased
Registration
21/07/2004, Ljubljana,
13654200 Statistical Nr.: 1732811 Tax Nr.: SI87916452
Owners and Capital
|
Crefo Nr. |
Name / Address / Status |
From |
Share |
|
Head shareholders |
|||
|
9270022638 |
NOVARTIS PHARMA AG Lichtstr. 35, Basel
Switzerland |
|
100% |
Registered capital
Date
|
Currency |
Value |
|
EUR |
48.402.003 |
Management
|
Crefo Nr. |
Name / Address / Status |
Since Power of attorney |
|
Board of Directors |
||
|
9270019046 |
Board member Bojan Dolenc Srednje Bitnje 11, 4209
Zabnica Slovenia |
|
|
9270038398 |
Board member Daniel Karrer Alramstrasse 20, 81371
Munchen Germany |
|
9270038404 |
Board member Ksenija Butenko Cerne Moskriceva ulica 2a, 1000
Ljubljana Slovenia |
|
9270135628 |
Board member Samo Ros Mladinska ulica 15, 1000
Ljubljana Slovenia |
|
9270030855 |
chairman of the board Vojmir Urlep RoZna ulica 13, 1370
Logatec Slovenia |
|
9270038397 |
Board member Zvonko Bogdanovski RoZnadolina, Cesta VI 1a,
1000 Ljubljana Slovenia |
|
Supervisory Board |
|
|
9270038407 |
member of the supervisory
board Aleksander Koren Groznikova ulica 17, 1000
Ljubljana Slovenia |
|
9270147509 |
member of the supervisory
board Cesare Frontini Baaderstrasse 1a, 80469
Munchen Germany |
|
9270146558 |
Vice chairman of the board
of directors George Jeffrey Pilgram JAKOB BUKHARDT STR. 61,
4052 BASEL USA |
|
9270038415 |
President Peter Goldschmidt Herterichstrasse 31, 81479
Munchen Germany |
|
9270038412 |
member of the supervisory
board Peter Rupprecht Nenzlingerweg 1, 4147
Aesch(BL) Switzerland |
|
9270038408 |
member of the supervisory
board Uros Urleb Podkoren 82d, 4280
Kranjska gora Slovenia |
Company addresses
|
Valid from |
Residence address |
Valid until |
|
|
Verovskova ulica 57, 1000
Ljubljana, Slovenia Phone: 01 580 21 11 Telefax: 01 568 35 17
E-Mail: info@lek.si
Web: www.lek.si |
|
Subsidiaries
|
Crefo Nr. |
Name / Address / Status |
Valid from |
Share |
|
Owner |
|||
|
9270074063 |
NOVARTIS VETERINA d.o.o. Statistical Nr.: 2036568 Verovskova ulica 57, 1000
Ljubljana Slovenia |
|
2.086.463 EUR |
|
9270038426 |
Hotel Lek d.o.o. Slovenia |
|
100 % |
|
9270038428 |
Novartis Veterina d.o.o.
Slovenia |
|
100 % |
|
9270038430 |
Lek Zagreb d.o.o. Croatia |
|
100 % |
|
9270038431 |
Lek Skopje d.o.o.
Macedonia |
|
100 % |
|
9270038432 |
Lek Ljubljana Holding GmbH
Austria |
|
100 % |
|
9270038433 |
Cistilna naprava Lendava
d.o.o. Slovenia |
|
74 % |
|
9270038434 |
Lek Pharmaceuticals Inc.
USA |
|
100 % |
|
9270071628 |
IEDC d.o.o. Statistical Nr.: 1197843 Presernova cesta 33, 4260
Bled Slovenia |
|
158.571 EUR |
|
Head shareholders |
|||
|
9270038429 |
Sandoz d.d. Statistical Nr.: 2159287 Verovskova ulica 57, 1000
Ljubljana Slovenia |
|
100 % |
Business activities
|
Main activity |
Nace |
|
Manufacture of
pharmaceutical preparations |
21.20 |
Additional activities Nace
Company
activity:
manufacture
of pharmaceutical preparations, chemicals, cosmetics, dental products, research
and development, quality control, advisory engineering, tourism, export-import
representation and mediation
(all this activities
are within the company since september 2004 after the incorporation of the
company Lek d.d., before the activity was only managing of the companies)
headquarters
and the part of the manufacture premises are located on the address above branc
offices are located:
in Menges,
Kolodvorska cesta 27 (manufacture of raw materials for the company use and for
further sale), - in Lendava, Trimlini 2D, (manufacture of cosmetics,
manufacture of
pharmaceutical
raw materials) - in Lipovci, Lipovci 251D, Beltinci (veterinary programme) - in
Prevalje, Perzonali 47 (dental programme) - Ljubljana, Celovska cesta 135
(research and development)
the
company has wide sales net and a great deal of
licence
partners who transfered their sales rights for
their
products on the company, for example:
Meck and
Co. (USA), Farmitalia (Italy), E.Merck
(Germany),
Ivoclar/Vivadent
(Lichtenstein), Revlon (USA) etc.
selling
structure: 77\/ Central-and Easteurope,
10\/ Asia and
Latin
Amerika,
9\%
Slovenia, 2\% Afrika,Australia, 2\% Westeuropa, USA, Canada
Economic data
Turnover and Employees
|
Date |
Turnover |
Employees |
|
2007 |
772.499.801 EUR |
2456 |
|
2008 |
729.193.527 EUR |
2500 |
|
2009 |
581.597.375 EUR |
2435 |
|
2010 |
575.865.113 EUR |
2472 |
|
group
Lek |
|
|
|
|
Annual |
turnover |
2010 |
EUR
734.517.330,-- |
|
Profit |
2010 EUR |
67.003.820,-- |
|
|
Annual |
turnover |
2009 |
EUR
731.591.573,-- |
|
Profit |
2009 |
EUR |
48.747.940,-- |
|
Annual |
turnover |
2008 |
EUR
831.502.677,-- |
|
Profit |
2008 |
EUR |
97.989.770,-- |
|
Annual |
turnover |
2007 |
EUR
973.760.702,-- |
|
Profit |
2007 |
EUR |
81.200.979,-- |
Import / Export
|
|
Import |
Export |
|
Percentage |
Unknown |
Unknown |
|
Countries |
India, Germany, Spain, Japan,
USA, China, Italy, Switzerland, Austria |
Unknown |
Properties
|
Name |
Detail |
Currency |
Value |
|
Land |
Company's property |
EUR |
14.533.997 |
|
|
458501 square metre |
|
|
|
|
per 31.12.2010 |
|
|
|
Buildings |
Company's property per 31.12.2010 |
EUR |
82.056.293 |
Supplementary data
Remarks
company name:
LEK farmacevtska druZba
d.d.firma v angleskem
jeziku: Lek Pharmaceuticals
d.d.firma v
franc.j:Societe
Pharmaceutique Lek d.d.
participation in capital:
Hotel Lek d.o.o. Kranjska
Gora(100% share)
Sandoz d.d.Ljubljana(100%
share)
CN Lendava d.o.o. (74,5%
share)
Novartis Veterina d.o.o.
Ljubljana (100% share)
Lek Ljubljana Holding GmbH
Austria(100% share)
Lek Skopje
d.o.o.Macedonia(100% share)
Lek Pharmaceuticals, Inc.
USA (100% share) (stand per 31.12.2010)
Representations are located
in BiH,
Georgien, Ukraine,
Kasachstan, Poland,
Russia, Usbekistan, Belaruss
Banks.
|
Code |
Bank name / Address |
Account Nr. |
|
122 |
ABANKA VIPAd.d. Slovenska cesta 58, 1517
Ljubljana , 1517, |
05100-8000005424 |
|
100 |
NOVA LJUBLJANSKA BANKA
d.d., LJUBLJANA Trg republike 2, 1520
Ljubljana , 1250, |
02923-0012224080 |
|
124 |
RAIFFEISEN BANKA d.d. Slovenska ulica 17, 2000
Maribor, 2000, |
SI56 242039062678839 |
|
134 |
UNICREDIT BANKA SLOVENIJA
d.d. Smartinska 140, 1000
Ljubljana , 1000, |
29000-0001867107 |
Main indices
Payment experience and
credit opinion
|
Terms of payment |
Within agreed terms |
(21) |
|
Business connection |
Business connection are
premissible |
(21) |
|
Credit Limit |
10.000.000 |
EUR |
Business development
|
Company development |
Constant |
(30) |
|
|
|
|
Events
No negative events
registered.
Balances
Balance
31.12.2010 The enclosed balance of 2010 is originated from
official source, it is authenticated by the auditor. 31.12.2009 The
enclosed balance of 2009 is originated from official source, it is
authenticated by the auditor. 31.12.2008
The enclosed balance of 2008 is originated
from official source, it is authenticated by the auditor. 31.12.2007 The
enclosed balance of 2007 is originated from official source, no data available
about authentication.
|
|
|
31/12/2010 1 EUR balance |
31/12/2009 1 EUR balance |
31/12/2008 1 EUR balance |
31/12/2007 1 EUR balance |
|
Name |
Ref. |
||||
|
ASSETS (AKTIVA) |
|
829.067.311 |
897.595.525 |
1.120.673.184 |
955.552.381 |
|
LONG-TERM ASSETS |
|
557.910.920 |
586.739.453 |
594.534.417 |
597.270.222 |
|
Intangible assets and
long-term deferred costs and accrued revenues |
|
341.924.167 |
342.328.717 |
342.681.153 |
342.695.346 |
|
Intangible assets |
|
341.896.682 |
342.328.717 |
|
|
|
Long-term deferred costs
and accrued revenues |
|
27.485 |
0 |
|
|
|
Tangible fixed assets |
|
206.449.360 |
225.935.390 |
232.731.041 |
217.802.317 |
|
Long-term financial
investments and Real estate investments |
|
9.537.393 |
18.474.130 |
18.474.648 |
35.806.201 |
|
|
|
31/12/2010 1 EUR balance |
31/12/2009 1 EUR balance |
31/12/2008 1 EUR balance |
31/12/2007 1 EUR balance |
|
Name |
Ref. |
||||
|
Investment property |
|
0 |
0 |
|
|
|
Long-term financial
investments |
|
9.537.393 |
18.474.130 |
|
|
|
Long-term operating
receivables |
|
0 |
1.216 |
4.767 |
170.767 |
|
Deferred receivables for
taxes |
|
0 |
0 |
642.808 |
795.591 |
|
SHORT-TERM ASSETS |
|
267.726.728 |
308.950.849 |
523.807.342 |
357.607.700 |
|
Short-term assets (without
Short-term deferred costs and accrued revenues) |
|
|
518.812.328 |
357.601.336 |
|
|
Assets (group for
estrange) for sell |
|
0 |
0 |
0 |
0 |
|
Inventories |
|
101.675.463 |
117.485.131 |
140.514.398 |
126.442.425 |
|
Short-term financial
investments |
|
77.582.565 |
17.785.028 |
4.995.014 |
6.364 |
|
Short-term operating
receivables |
|
88.317.283 |
172.696.267 |
376.576.035 |
226.109.407 |
|
Cash assets |
|
151.417 |
984.423 |
1.721.895 |
5.049.504 |
|
Short-term deferred costs
and accrued revenues |
|
3.429.663 |
1.905.223 |
2.331.425 |
674.459 |
|
Off-balance sheet items |
|
6.523.939 |
10.307.379 |
|
|
|
LIABILITIES |
|
829.067.311 |
897.595.525 |
1.120.673.184 |
955.552.381 |
|
Long-term sources
(PASSIVA) |
|
|
732.047.288 |
850.333.923 |
|
|
CAPITAL |
|
675.660.658 |
707.751.768 |
701.504.759 |
753.771.146 |
|
Called-up capital |
|
48.402.003 |
48.402.003 |
|
|
|
Basic (subscribed) capital |
|
48.402.003 |
48.402.003 |
48.402.003 |
48.402.003 |
|
Non called-up capital
(deductive item) |
|
0 |
0 |
|
|
|
Capital reserves |
|
575.595.036 |
575.595.036 |
575.595.036 |
575.595.036 |
|
Reserves from profit |
|
0 |
0 |
|
|
|
Surplus from revaluation |
|
0 |
0 |
|
|
|
Retained net |
|
3.754.729 |
28.453.018 |
10.078.106 |
49.988.349 |
|
Net business result for
the business year |
|
47.908.890 |
55.301.711 |
67.429.614 |
79.785.758 |
|
PROVISIONS AND LONG-TERM
ACCRUED COSTS AND DEFERRED REVENUES |
|
31.288.969 |
30.053.561 |
30.447.967 |
|
|
FINANCIAL AND BUSINESS
LIABILITIES |
|
108.829.120 |
145.407.313 |
344.705.491 |
|
|
LONG-TERM LIABILITIES |
|
7.446.508 |
7.664.308 |
30.542.529 |
96.562.777 |
|
Provisions and long-term
accrued costs and deferred revenues |
|
|
30.447.967 |
32.605.757 |
|
|
Long-term liabilities |
|
|
94.562 |
63.957.020 |
|
|
Long-term financial liabilities |
|
0 |
0 |
0 |
63.820.704 |
|
Long-term operating
liabilities |
|
0 |
0 |
94.562 |
136.316 |
|
Deferred liabilities for
taxes |
|
7.446.508 |
7.664.308 |
|
|
|
Short-term liabilities and
accruals |
|
|
388.625.896 |
105.218.458 |
|
|
SHORT-TERM LIABILITIES |
|
101.382.612 |
137.743.005 |
344.610.929 |
89.818.448 |
|
Liabilities, included in
groups for estrange |
|
0 |
0 |
|
|
|
Short-term financial
liabilities |
|
13.229.506 |
58.850.943 |
268.119.385 |
5.316.943 |
|
Short-term operating
liabilities |
|
88.153.106 |
78.892.062 |
76.491.544 |
84.501.505 |
|
SHORT-TERM ACCRUED COSTS
AND DEFERRED REVENUES |
|
13.288.564 |
14.382.883 |
44.014.967 |
15.400.010 |
|
|
|
31/12/2010 1 EUR balance |
31/12/2009 1 EUR balance |
31/12/2008 1 EUR balance |
31/12/2007 1 EUR balance |
|
Name |
Ref. |
||||
|
Off-balance sheet items |
|
6.523.939 |
10.307.379 |
|
|
|
Profit and loss accounts |
|
|
|
|
|
|
31.12.2010 The enclosed profit and loss account of 2010 is
originated from official source, it is authenticated by the auditor. 31.12.2009 The enclosed profit and loss account of 2009 is
originated from official source, it is authenticated by the auditor. 31.12.2008 The enclosed profit and loss account of 2008 is
originated from official source, it is authenticated by the auditor. 31.12.2007 The enclosed profit and loss account of 2007 is
originated from official source, no data available about authentication. |
|||||
|
|
|
31/12/2010 1 EUR profit and loss account |
31/12/2009 1 EUR profit and loss account |
31/12/2008 1 EUR profit and loss account |
31/12/2007 1 EUR profit and loss account |
|
Name |
Ref. |
||||
|
TOTAL REVENUES |
|
|
729.193.527 |
772.499.801 |
|
|
TOTAL EXPENSES |
|
|
647.450.540 |
671.405.783 |
|
|
CAPITAL |
|
|
|
|
|
|
Net sales |
|
552.515.632 |
561.687.358 |
|
|
|
Changes in the value of
inventories of products and work-in-process |
|
-5.243.600 |
-16.157.290 |
|
|
|
Capitalised own products
and own services |
|
0 |
0 |
|
|
|
Other operating revenues
(with subventions, grants,...) |
|
20.376.458 |
16.859.693 |
|
|
|
GROSS OPERATING YIELD |
|
567.648.490 |
562.389.761 |
|
|
|
Cost of goods, material
and services |
|
341.427.559 |
312.926.272 |
218.110.121 |
304.802.964 |
|
Purchase value of goods
and materials sold and cost of material and cost of material used |
|
234.999.001 |
214.678.293 |
|
|
|
Cost of services |
|
106.428.558 |
98.247.979 |
213.055.699 |
157.090.969 |
|
Labour cost |
|
122.310.407 |
122.544.720 |
125.095.179 |
129.344.796 |
|
thereof wages |
|
|
89.565.176 |
91.609.726 |
|
|
Cost of wages |
|
88.594.904 |
85.345.680 |
|
|
|
Cost of pension insurance |
|
12.204.350 |
11.663.338 |
|
|
|
Cost of other social
insurance |
|
6.673.066 |
6.515.984 |
|
|
|
Other labour cost |
|
14.838.087 |
19.019.718 |
|
|
|
Write-offs |
|
47.607.464 |
51.465.285 |
|
|
|
Depreciation |
|
46.607.426 |
50.806.079 |
55.803.966 |
54.623.610 |
|
Revaluation operating
expenses for non-tangible assets and tangible fixed assets |
|
318.338 |
494.920 |
|
|
|
Revaluation operating
expenses for current assets |
|
681.700 |
164.286 |
|
|
|
Other operating expenses |
|
2.535.508 |
1.898.229 |
2.246.144 |
2.554.609 |
|
OPERATING REVENUES |
|
572.892.090 |
578.547.051 |
700.951.673 |
746.309.933 |
|
Financial Revenues from
salles of goods, services and materials |
|
|
684.066.202 |
738.413.029 |
|
|
OPERATING EXPENSES |
|
513.880.938 |
488.834.506 |
614.710.468 |
649.217.555 |
|
OPERATING RESULT |
|
59.011.152 |
89.712.545 |
|
|
|
EBIT |
|
53.767.552 |
73.555.255 |
|
|
|
|
|
31/12/2010 1 EUR profit and loss account |
31/12/2009 1 EUR profit and loss account |
31/12/2008 1 EUR profit and loss account |
31/12/2007 1 EUR profit and loss account |
|
||
|
Name |
Ref. |
|
||||||
|
Financial income from
investments in other enterprises |
|
922.626 |
61.137 |
8.006.889 |
14.123.002 |
|
||
|
Financial income from
loans |
|
462.769 |
774.109 |
|
|
|
|
|
|
Financial income from
operating receivables |
|
6.617.210 |
18.291.581 |
|
|
|
|
|
|
Financial expenses from
depreciation and writeoffs of financial investments |
|
0 |
1.676 |
0 |
4.538.125 |
|
||
|
Financial expenses from
financial liabilities |
|
449.279 |
6.990.167 |
|
|
|
|
|
|
Financial expenses from
operating liabilities |
|
4.747.164 |
18.223.006 |
|
|
|
|
|
|
Financial income |
|
8.002.605 |
19.126.827 |
26.453.361 |
26.113.231 |
|
||
|
Financial expenses |
|
5.196.443 |
25.214.849 |
32.561.726 |
21.975.860 |
|
||
|
Other revenues |
|
214.018 |
80.787 |
1.788.493 |
76.637 |
|
||
|
Other expenses |
|
1.023.711 |
596.365 |
178.346 |
212.368 |
|
||
|
Total revenues |
|
575.865.113 |
581.597.375 |
|
|
|
|
|
|
Total costs |
|
520.101.092 |
514.645.720 |
|
|
|
|
|
|
Total business result |
|
55.764.021 |
66.951.655 |
|
|
|
|
|
|
Tax on profit |
|
8.072.931 |
11.865.034 |
|
|
|
|
|
|
Deferred taxs |
|
-217.800 |
-215.090 |
|
|
|
|
|
|
Net business result for
the accounting period |
|
47.908.890 |
55.301.711 |
|
|
|
|
|
|
Write-offs of equity and
other financial investments |
|
|
|
32.561.726 |
17.437.735 |
|
||
|
EARNINGS BEFORE TAXES
(EBT) |
|
|
|
81.742.987 |
101.094.018 |
|
||
|
INCOME TAX |
|
|
|
14.313.373 |
21.308.260 |
|
||
|
NET EARNINGS (E) |
|
|
|
67.429.614 |
79.785.758 |
|
||
|
Financial Ratios |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name |
Ref. |
31/12/2010 |
31/12/2009 |
31/12/2008 |
31/12/2007 |
|||
|
Equity ratio |
1 |
0,06 |
0,05 |
0,04 |
0,05 |
|||
|
Cleared equity ratio |
2 |
0,06 |
0,05 |
0,04 |
0,05 |
|||
|
Current liquidity |
3 |
2,64 |
2,24 |
1,52 |
3,98 |
|||
|
Quick liquidity |
4 |
1,64 |
1,39 |
1,11 |
2,57 |
|||
|
Working capital |
5 |
166344116,00 |
171207844,00 |
179196413,00 |
267789252,00 |
|||
|
Gearing |
6 |
17,13 |
18,54 |
23,15 |
19,74 |
|||
|
Cleared gearing |
7 |
0,27 |
1,22 |
|
||||
|
Profitability |
8 |
9,68 |
11,51 |
11,21 |
13,09 |
|||
|
Operating profitability |
9 |
8,32 |
9,51 |
9,25 |
10,33 |
|||
|
Stock days |
10 |
64,44 |
73,73 |
70,33 |
59,74 |
|||
|
Debtor days |
11 |
55,98 |
108,38 |
188,50 |
106,83 |
|||
|
Supplier days |
12 |
55,87 |
49,51 |
38,29 |
39,93 |
|||
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.49.07 |
|
|
1 |
Rs.78.09 |
|
Euro |
1 |
Rs.65.15 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SCs credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.